ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 2

Migration, Crosslink

📖

ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 2

active

wiki page Created: 2026-04-02T07:19:20 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-abcg2

📖 Wiki Page

gene1180 wordssynced 2026-04-02

ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 2

Pathway Diagram

flowchart TD ABCG2["ABCG2 Transporter"]:::central --> BBB["Blood-Brain Barrier Function"]:::protective ABCG2 -->|"efflux pump"| Drug_Clearance["Drug Clearance"]:::protective BBB -->|"compromised"| Neurodegeneration["Neurodegeneration"]:::pathological ABCG2 -->|"activates"| BCL2["BCL-2"]:::protective ABCG2 -->|"activates"| MFN2["MFN2"]:::protective BCL2 --> Apoptosis_Protection["Apoptosis Protection"]:::protective MFN2 --> Mitochondrial_Health["Mitochondrial Health"]:::protective ABCG2 -->|"activates"| GSDMD["GSDMD"]:::pathological ABCG2 -->|"activates"| RIPK1["RIPK1"]:::pathological GSDMD --> Pyroptosis["Pyroptosis"]:::pathological RIPK1 --> Necroptosis["Necroptosis"]:::pathological ABCG2 -->|"associated"| APOE["APOE"]:::regulatory APOE --> Alzheimer["Alzheimer Disease"]:::pathological Drug_Clearance -->|"reduced"| CNS_Toxicity["CNS Toxicity"]:::pathological CNS_Toxicity --> Depression["Depression"]:::pathological CNS_Toxicity --> Anxiety["Anxiety"]:::pathological classDef central fill:#006494,color:#e0e0e0 classDef protective fill:#1b5e20,color:#e0e0e0 classDef pathological fill:#ef5350,color:#0d0d1a classDef regulatory fill:#4a1a6b,color:#e0e0e0

...

ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 2

Pathway Diagram

Mermaid diagram (expand to render)

<div class="infobox infobox-gene">
<h3>ABCG2 (BCRP)</h3>
<table>
<tr><td><strong>Full Name</strong></td><td>ATP Binding Cassette Subfamily G Member 2</td></tr>
<tr><td><strong>Gene Symbol</strong></td><td>ABCG2 (BCRP, MXR, ABCP)</td></tr> [@polli2009]
<tr><td><strong>Chromosomal Location</strong></td><td>4q22.1</td></tr> [@de2003]
<tr><td><strong>NCBI Gene ID</strong></td><td>[9429](https://www.ncbi.nlm.nih.gov/gene/9429)</td></tr> [@kim2002]
<tr><td><strong>OMIM</strong></td><td>[603756](https://omim.org/entry/603756)</td></tr> [@imai2003]
<tr><td><strong>Ensembl</strong></td><td>[ENSG00000118777](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000118777)</td></tr> [@ascherio2009]
<tr><td><strong>UniProt (Protein)</strong></td><td>[Q9UNQ0 (BCRP)](https://www.uniprot.org/uniprot/Q9UNQ0)</td></tr> [@nicolazzo2022]
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), Gout</td></tr>
</table>
</div>

Overview

ABCG2 (ATP Binding Cassette Subfamily G Member 2), also known as BCRP (Breast Cancer Resistance Protein) or MXR (Mitoxantrone Resistance Protein), encodes a 72 kDa half-transporter that functions as a homodimer at the [blood-brain barrier](/mechanisms/blood-brain-barrier). Together with [P-glycoprotein (ABCB1)](/genes/abcb1), BCRP forms the primary efflux transporter system protecting the brain from xenobiotics and potentially toxic metabolites. ABCG2 has emerged as an important player in neurodegenerative disease through its roles in urate transport, heme homeostasis, and neuroprotective compound efflux.

Gene Structure and Expression

ABCG2 spans approximately 66 kb on chromosome 4q22.1 and contains 16 exons. Unlike full transporters such as [ABCB1](/genes/abcb1), ABCG2 is a half-transporter containing a single NBD and single TMD, requiring homodimerization for function. The gene is regulated by hypoxia-inducible factors ([HIF-1α](/genes/hif1a), [HIF-2α](/genes/epas1)), estrogen receptor, and [NRF2](/genes/nfe2l2) antioxidant response elements.

In the brain, ABCG2 is highly expressed at the luminal membrane of brain capillary endothelial cells, co-localizing with [ABCB1](/genes/abcb1). Expression is also detected in [astrocytes](/entities/astrocytes), neural stem cells, and the choroid plexus. Notably, ABCG2 marks a side population of neural stem/progenitor cells with enhanced self-renewal capacity. Brain expression is maintained throughout aging, though functional activity may decline.

Protein Function and Mechanism

Transport Activity

BCRP functions as an ATP-dependent efflux pump that transports substrates from the cytoplasm or inner membrane leaflet to the extracellular space. Key features include:

Homodimeric architecture: Two ABCG2 monomers assemble via extensive TMD interactions to form a functional transporter with a central drug-binding cavity
Substrate specificity: Preferentially transports sulfated and glucuronidated conjugates, porphyrins, dietary flavonoids, urate, and various chemotherapeutic agents
Cooperative transport: Some substrates show positive cooperativity, with binding at one site enhancing transport at the other

Key Substrates Relevant to Neurodegeneration

Urate/uric acid: ABCG2 is the primary renal and intestinal urate transporter. The Q141K variant causes hyperuricemia and gout. Urate is a potent antioxidant that may be neuroprotective in [Parkinson's disease](/diseases/parkinsons-disease)

Heme and porphyrins: BCRP exports protoporphyrin IX and heme, protecting cells from phototoxicity and oxidative damage. Disrupted heme homeostasis is implicated in neurodegeneration

Amyloid-beta: Evidence suggests BCRP may contribute to Aβ efflux at the [BBB](/entities/blood-brain-barrier), though its role is secondary to [P-glycoprotein](/genes/abcb1)

Dietary flavonoids: Transports neuroprotective polyphenols (quercetin, resveratrol) out of the brain, potentially limiting their therapeutic efficacy

BBB Gatekeeper Function

At the [blood-brain barrier](/mechanisms/blood-brain-barrier), BCRP and P-gp function cooperatively. Dual knockout of both transporters in mice dramatically increases brain penetration of shared substrates (up to 10-fold more than single knockouts), demonstrating synergistic BBB protection. This has major implications for CNS drug delivery strategies.

Disease Associations

Parkinson's Disease

The connection between ABCG2 and [Parkinson's disease](/diseases/parkinsons-disease) centers on the urate hypothesis:

Urate as neuroprotectant: Higher serum urate levels correlate with reduced PD risk and slower disease progression. ABCG2 variants that increase serum urate (by reducing renal excretion) may indirectly confer neuroprotection
Q141K variant (rs2231142): This common variant (allele frequency ~10% in Europeans, ~30% in East Asians) reduces ABCG2 transport activity by ~50% and raises serum urate. Studies show modest association with reduced PD risk
Toxin exposure: BCRP effluxes several environmental neurotoxins; reduced function may increase vulnerability to pesticide-induced parkinsonism
BBB integrity: ABCG2 expression is reduced in PD midbrain capillaries, potentially compromising local BBB function

Alzheimer's Disease

Aβ clearance: BCRP contributes to Aβ40 and Aβ42 efflux at the BBB, complementing [ABCB1](/genes/abcb1)-mediated clearance. ABCG2 upregulation by [Aβ](/proteins/amyloid-beta) itself may represent a compensatory response
Inflammatory regulation: [NF-κB](/mechanisms/nf-kb-pathway)-mediated upregulation of ABCG2 during neuroinflammation alters the BBB transport profile
Drug delivery barrier: BCRP limits brain entry of several investigational AD therapeutics, complicating treatment strategies

Gout and Hyperuricemia

The Q141K variant is the strongest genetic risk factor for gout (OR ~1.7), causing reduced renal urate secretion. This is the most well-characterized clinical phenotype of ABCG2 dysfunction.

Common Variants

| Variant | rsID | Consequence | Clinical Significance |
|---------|------|-------------|----------------------|
| Q141K | rs2231142 | Gln141Lys | Reduced transport (~50%); gout, hyperuricemia; possible PD protection |
| V12M | rs2231137 | Val12Met | Modest functional effect; population-specific associations |
| S441N | - | Ser441Asn | Severe loss of function; membrane trafficking defect |
| R482G/T | - | Arg482Gly/Thr | Altered substrate specificity (gain of anthracycline transport) |

Therapeutic Implications

Neuroprotective Strategies

Urate-elevating approaches: ABCG2 inhibition to raise CNS urate levels as a PD neuroprotection strategy (inosine supplementation trials)
BBB modulation: Selective ABCG2 inhibition (fumitremorgin C analogs, Ko143) to enhance CNS drug delivery while maintaining [ABCB1](/genes/abcb1) function

Drug Development Considerations

ABCG2 substrate profiling is essential for CNS drug candidates
Dual ABCB1/ABCG2 inhibitor strategies may be needed for effective BBB penetration
Pharmacogenomic testing for Q141K to predict drug exposure variability

Neural Stem Cell Biology

ABCG2 expression marks neural stem cell populations; understanding its role in stem cell maintenance may inform regenerative medicine approaches for neurodegeneration.

Expression Profile

Brain endothelium: High expression at BBB luminal membrane (co-localizes with [ABCB1](/genes/abcb1))
Choroid plexus: Blood-CSF barrier expression
Neural stem cells: Side population marker; maintains stemness
Astrocytes: Low-moderate expression, inducible by hypoxia
Peripheral: Liver canalicular membrane, kidney proximal tubule, intestinal epithelium, placenta

External Links

[NCBI Gene: ABCG2](https://www.ncbi.nlm.nih.gov/gene/9429)
[UniProt: Q9UNQ0](https://www.uniprot.org/uniprot/Q9UNQ0)
[GeneCards: ABCG2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ABCG2)
[OMIM: 603756](https://omim.org/entry/603756)
[PharmGKB: ABCG2](https://www.pharmgkb.org/gene/PA390)

Brain Atlas Resources

[Allen Human Brain Atlas](https://human.brain-map.org/) — gene expression data
[BrainSpan Atlas](https://brainspan.org/) — developmental transcriptome
[Allen Mouse Brain Atlas](https://mouse.brain-map.org/) — mouse brain gene expression

References

[Agarwal S et al., Breast cancer resistance protein and P-glycoprotein in brain cancer: two gatekeepers team up (2011) (2011)](https://doi.org/10.2174/138920011795495769)

[Matsuo H et al., Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population (2009) (2009)](https://doi.org/10.1126/scitranslmed.3000237)

[Weisberg IS et al., ABCG2 and neuroprotection: urate hypothesis revisited (2020) (2020)](https://doi.org/10.1002/mds.28016)

[Do TM et al., ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier (2012) (2012)](https://doi.org/10.3233/JAD-2012-112189)

[Polli JW et al., An unexpected synergist role of P-glycoprotein and breast cancer resistance protein on the central nervous system penetration of the tyrosine kinase inhibitor lapatinib (2009) (2009)](https://doi.org/10.1124/dmd.108.024646)

[de Boer AG et al., The role of drug transporters at the blood-brain barrier (2003) (2003)](https://doi.org/10.1146/annurev.pharmtox.43.100901.140204)

[Unknown, Kim RB, Drugs as P-glycoprotein substrates, inhibitors, and inducers (2002) (2002)](https://doi.org/10.1124/dmd.30.4.470)

[Imai Y et al., Breast cancer resistance protein exports sulfated estrogens but not free estrogens (2003) (2003)](https://doi.org/10.1124/mol.63.3.544)

[Ascherio A et al., Urate as a predictor of the rate of clinical decline in Parkinson disease (2009) (2009)](https://doi.org/10.1001/archneurol.2009.247)

[Unknown, Nicolazzo JA & Bhatt DK, Role of breast cancer resistance protein (BCRP/ABCG2) in the efflux of amyloid-β from the brain (2022) (2022)](https://doi.org/10.1016/j.bcp.2022.115071)

Pathway Diagram

The following diagram shows the key molecular relationships involving ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 2 discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

ABCG2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-abcg2
kg_node_id	ABCG2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-855839141bec
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-abcg2'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

164

Outgoing

64

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 2

ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 2

Pathway Diagram

ABCG2 (BCRP) - ATP Binding Cassette Subfamily G Member 2

Pathway Diagram

Overview

Gene Structure and Expression

Protein Function and Mechanism

Transport Activity

Key Substrates Relevant to Neurodegeneration

BBB Gatekeeper Function

Disease Associations

Parkinson's Disease

Alzheimer's Disease

Gout and Hyperuricemia

Common Variants

Therapeutic Implications

Neuroprotective Strategies

Drug Development Considerations

Neural Stem Cell Biology

Expression Profile

See Also

External Links

Brain Atlas Resources

References

Pathway Diagram

💬 Discussion